Details for Patent: 12,042,504

Which drugs does patent 12,042,504 protect, and when does it expire?

Patent 12,042,504 protects FOCINVEZ and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 12,042,504

Title:	Injectable fosaprepitant composition
Abstract:	The present application and its embodiments teach stable compositions of fosaprepitant or a pharmaceutically acceptable salt thereof with such compositions lacking polysorbate 80 and containing dual functional excipients of hydrolysis inhibition and solubility enhancement. Further described are methods of preparation of such compositions. Among other advantages of contemplated compositions, fosaprepitant hydrolysis degradation is kept low and the compositions maintain physically and chemically stable for prolonged period.
Inventor(s):	Jianwei Yu, Yulu Wang
Assignee:	Spes Pharmaceuticals Inc
Application Number:	US17/379,999
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 12,042,504

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Steriscience	FOCINVEZ	fosaprepitant dimeglumine	SOLUTION;INTRAVENOUS	216686-001	Aug 22, 2023		RX	Yes	Yes	12,042,504		Y

International Family Members for US Patent 12,042,504

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	112243376
World Intellectual Property Organization (WIPO)	2019221815